(800) 266-7207 investor@navf.net
Native American Venture Fund, LLC
  • Home
  • About Us
  • Invest Now
  • News
  • Contact Us
Select Page

Study: Frequent neurologic manifestations and encephalopathy-associated morbidity in Covid-19 patients

by navf admin | Nov 1, 2021 | News

By: Eric M. Liotta,Ayush Batra,Jeffrey R. Clark,Nathan A. Shlobin,Steven C. Hoffman,Zachary S. Orban,Igor J. Koralnik Annals of Clinical and Translational Neurology Published:  05 October 2020 Full Study Covid-19 can involve multiple organs including the nervous...
Study: Optical Biosensors for Virus Detection: Prospects for SARS-CoV-2/COVID-19

Study: Optical Biosensors for Virus Detection: Prospects for SARS-CoV-2/COVID-19

by navf admin | Nov 1, 2021 | News

By: Hemanth Maddali,Catherine E. Miles,Prof. Joachim Kohn,Prof. Deirdre M. O’Carroll, Chemistry Europe Published: 29 October 2020 Full Study Optical biosensors have led to significant advancements in virus detection and imaging capabilities. Coupled with...

Study: SARS-CoV-2 Transmission From People Without COVID-19 Symptoms

by navf admin | Nov 1, 2021 | News

By: Michael A. Johansson, PhD; Talia M. Quandelacy, PhD, MPH; Sarah Kada, PhD; JAMA Netw Open. 2021;4(1) Published:  January 07 2021 Full Study Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the etiology of coronavirus disease 2019 (COVID-19), is...

Study: Comparative evaluation of 19 reverse transcription loop-mediated isothermal amplification assays for detection of SARS-CoV-2

by navf admin | Nov 1, 2021 | News

By: Yajuan Dong, Xiuming Wu, Shenwei Li, Renfei Lu, Yingxue Li, Zhenzhou Wan, Jianru Qin, Guoying Yu, Xia Jin & Chiyu Zhang Scientific Reports volume 11, Article number: 2936 (2021) Published:  03 February 2021 Full Study Coronavirus disease 2019 (COVID-19) caused...

Study: Lateral flow tests cannot rule out SARS- CoV-2 infection

by navf admin | Nov 1, 2021 | News

By: Jonathan J Deeks, Angela E Raffle, British Medical Journal 2020;371:m4787 Published:  11 December 2020 Full Study Lateral flow devices for asymptomatic mass testing are proving controversial. At the heart of the matter is a flawed process, with the decision to...
« Older Entries
Next Entries »

Recent Posts

  • The Pandemic Is NOT Over
  • Omicron
  • Study: Is increased time to diagnosis and treatment in symptomatic cancer associated with poorer outcomes? Systematic review
  • Study: Non-Classical monocytes display inflammatory features: Validation in Sepsis and Systemic Lupus Erythematous
  • Study: CD16 is indispensable for antibody-dependent cellular cytotoxicity by human monocytes

Recent Comments

No comments to show.

Company

  • About Us
  • Meet Our Team
  • Invest Now
  • Latest News
  • Contact Us
  • Sitemap

Sponsors

Get in touch



30 Wall Street, 8th Floor New York, NY 10005



+1 212-634-4300



investor@navf.net

  • Follow

Copyright © 2023 Native American Venture Fund, LLC | Powered by Native American Venture Fund, LLC